-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Multiple sclerosis (MS) is the most common type of central nerve demyelination disease
Multiple sclerosis (MS) is the most common type of central nerve demyelination disease
25 Italian MS patients participated in this prospective, multi-center observational study.
This article was published in " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry )
3 24 pwMS vaccinated with Swiss/BioNTech BNT162b2 vaccine
24 pwMS vaccinated with Swiss/BioNTech BNT162b2 vaccine
Patient characteristics
The safety of vaccines in PWMS has always been the focus of controversy
Our preliminary analysis indicated that the Pfizer/BioNTech BNT162b2 vaccine does not increase the short-term risk of clinical reactivation of pwMS
Di FilippoM ,CordioliC ,MalucchiS Di FilippoMDi Filippo CordioliCCordioli MalucchiSMalucchi, et almRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry Published Online First: 18 August 2021.
Published Online First: doi: 10.
1136/jnnp-2021-327200doi:
Leave a message here